In 2007, the echinoderm microtubule-associated protein-like 4 (EML4)–anaplastic lymphoma kinase (ALK) gene rearrangement was first discovered as a driver oncogene for non-small cell lung cancer (NSCLC) (1). This evidence concerns the gene EML4 and non-small cell lung carcinoma.